SI-BONE Cash Flow Statement
NASDAQ: SIBNHealth CareMedical/Dental InstrumentsUSD
19.37+0.51 (+2.70%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
SI-BONE free cash flow
In fiscal 2025, SI-BONE generated -$675,000 of operating cash flow and spent $8.4 million on capital expenditures. That left free cash flow of -$9.1 million, a free-cash-flow margin of -4.5% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
SI-BONE cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -18.90M | -30.91M | -43.34M | -61.26M | -56.57M | -43.70M | -38.40M | -17.45M | -23.04M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 5.77M | 4.38M | 5.43M | 3.45M | 2.09M | 1.13M | 774.00K | 722.00K | 1.01M |
| Stock-Based Compensation | 25.52M | 25.87M | 24.06M | 23.06M | 16.87M | 11.93M | 7.46M | 2.31M | 1.44M |
| Change in Working Capital | -14.32M | -10.12M | -4.83M | -7.96M | -5.76M | -2.53M | -479.00K | -1.03M | 382.00K |
| Operating Cash Flow | -675.00K | -12.43M | -18.71M | -41.66M | -39.53M | -30.66M | -31.63M | -14.52M | -17.53M |
| Capital Expenditures | -8.41M | -10.50M | -7.80M | -9.51M | -6.39M | -2.56M | -2.44M | -942.00K | -478.00K |
| Investing Cash Flow | 4.16M | 12.62M | -59.80M | -2.81M | 51.58M | -62.92M | 13.49M | -97.83M | -478.00K |
| Share Repurchases | — | — | — | — | — | — | -38.00K | -73.00K | 0 |
| Debt Issued | 0 | 35.95M | 35.96M | 0 | 35.00M | 45.30M | 0 | 0 | 40.00M |
| Debt Repaid | 0 | -36.00M | -35.27M | 0 | -41.00M | -45.30M | 0 | 0 | -1.12M |
| Financing Cash Flow | 3.38M | 1.96M | 90.93M | 2.20M | -1.71M | 136.40M | 3.49M | 115.15M | 12.86M |
| Net Change in Cash | 7.29M | 1.68M | 12.55M | -42.70M | 9.84M | 43.15M | -14.69M | 2.71M | -5.49M |
| Free Cash Flow | -9.09M | -22.92M | -26.51M | -51.16M | -45.92M | -33.22M | -34.07M | -15.46M | -18.01M |
This table shows 9 annual periods of SI-BONE's cash flow statement, from FY 2025 back to FY 2017, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SIBN's reporting calendar. What is a cash flow statement?